| 1177 |
Centers for Disease Control and Prevention |
Html |
en |
New CDC Data on Foodborne Disease Outbreaks | CDC Features |
Outbreaks provide important insights into how germs spread, which food and germ combinations cause illnesses, and how to prevent infections. Public health and industry use outbreak data to create information on prevention, education, and policy. |
| industry use outbreak | 0.26653 |
| appropriate control measures | 0.274278 |
| outbreak reports | 0.264933 |
| Outbreak-associated hospitalizations | 0.248076 |
| sit-down dining style | 0.291517 |
| Search CDC | 0.222802 |
| germ combinations | 0.226375 |
| common single food | 0.29574 |
| expert tips | 0.200982 |
| Foodborne Outbreak Online | 0.347553 |
| tribal health departments | 0.267481 |
| human impact | 0.210546 |
|
| state health departments | 0.305579 |
| Public health | 0.214035 |
| food poisoning | 0.310588 |
| interactive e-Learning course | 0.27722 |
| banquet facilities | 0.201228 |
| foodborne disease outbreaks | 0.908224 |
| unpasteurized dairy products | 0.31234 |
| long history | 0.219174 |
| outbreak data | 0.464254 |
| single known food | 0.294974 |
| single food category | 0.282007 |
| important insights | 0.21863 |
|
CLICK HERE |
| 1283 |
Centers for Disease Control and Prevention |
Html |
en |
Science Clips - Monday, July 21, 2014 |
CDC - Stephen B. Thacker Library - Science Clips |
| Trop Med Hyg. | 0.760597 |
| Sex Transm Dis. | 0.657005 |
| mental health | 0.666642 |
| Control Hosp Epidemiol. | 0.653164 |
| syncytial virus-associated hospitalizations | 0.659589 |
| Foodborne Pathog Dis. | 0.653776 |
| science clips | 0.659078 |
| macrolide-resistant Treponema pallidum | 0.652182 |
| PLoS One. | 0.684204 |
| Influenza Other Respir | 0.721336 |
| 2011-12 influenza season | 0.675512 |
| CDC Science Clips | 0.658558 |
| Emerg Infect Dis. | 0.661827 |
| cross-sectional study | 0.655506 |
| U.S. medical facilities | 0.651564 |
| Morb Mortal Wkly | 0.755786 |
| Appl Environ Microbiol. | 0.653573 |
| Environ Health Perspect. | 0.674006 |
| Emergency department visits | 0.695032 |
| Mendelian randomisation analysis | 0.65913 |
| Maitland-van der Zee | 0.653614 |
| environmental Vibrio cholerae | 0.652107 |
| Kachur SP | 0.652505 |
| Respir Crit Care | 0.658243 |
| Respir Viruses. | 0.710221 |
|
| Health Policy Plan. | 0.669421 |
| respiratory virus infections | 0.656832 |
| acute respiratory infection | 0.650781 |
| MMWR Morb Mortal | 0.755794 |
| public health community | 0.68884 |
| international cohort studies | 0.651825 |
| public health approach | 0.677497 |
| Occup Environ Med. | 0.654746 |
| non-communicable disease risk | 0.662269 |
| White Program-funded HIV | 0.650887 |
| PLoS Negl Trop | 0.669081 |
| Mortal Wkly Rep. | 0.749309 |
| public health | 0.779234 |
| Jul | 0.962949 |
| individual participant data | 0.656474 |
| public health literature | 0.670617 |
| B. Thacker CDC | 0.652345 |
| Public Health Action. | 0.729456 |
| Clin Vaccine Immunol. | 0.656921 |
| influenza virus types | 0.682741 |
| cryptococcal antigen positivity | 0.652768 |
| mental health conditions | 0.664341 |
| influenza diagnostic tests | 0.667983 |
| public health research | 0.688752 |
|
CLICK HERE |
| 5930 |
Centers for Disease Control and Prevention |
Html |
en |
2-Ethoxyethyl acetate - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 9089 |
Centers for Disease Control and Prevention |
Html |
en |
Update: Recommendations for Middle East Respiratory SyndromeCoronavirus MERS-CoV |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.447567 |
| control recommendations | 0.430855 |
| case investigation | 0.430037 |
| Hospital outbreak | 0.427614 |
| Human Services | 0.536896 |
| assistive technology | 0.448302 |
| Engl J Med | 0.440209 |
| U.S. Department | 0.534078 |
| MMWR HTML versions | 0.524261 |
| CDC Emergency Operations | 0.599968 |
| electronic PDF version | 0.514433 |
| interim infection prevention | 0.597204 |
| Recent published reports | 0.55025 |
| East respiratory syndrome | 0.921509 |
| human-to-human transmission | 0.425252 |
| Additional information | 0.433606 |
| Contact GPO | 0.442109 |
| preparedness resources | 0.435824 |
| routine operations | 0.430609 |
| health-care organizations | 0.510004 |
| MERS-CoV patients | 0.466225 |
| original paper copy | 0.519099 |
| rapid detection | 0.427729 |
| specimen collection | 0.428087 |
|
| United States | 0.43684 |
| U.S. Government Printing | 0.534191 |
| original MMWR paper | 0.520894 |
| infection control | 0.467869 |
| infection prevention measures | 0.585245 |
| U.S. hospitals | 0.443212 |
| Front-line providers | 0.439681 |
| health-care personnel | 0.634523 |
| MMWR readers | 0.427742 |
| Middle East | 0.685875 |
| infectious patients | 0.442756 |
| local health departments | 0.531833 |
| MERS-CoV cases | 0.467353 |
| international settings | 0.43009 |
| CDC MERS | 0.517693 |
| subject line | 0.446556 |
| paper copy | 0.527903 |
| MERS-CoV infection | 0.490478 |
| Perl TM | 0.427535 |
| U.S. health-care | 0.523768 |
| key actions | 0.425651 |
| respiratory syndrome coronavirus | 0.980011 |
| limited health-care transmission | 0.630969 |
| current information | 0.436971 |
|
CLICK HERE |
| 9949 |
Centers for Disease Control and Prevention |
Html |
en |
CDC Online Newsroom - Digital Press Kit: CDC Responds to Multistate Meningitis Outbreak - photos |
CDC Responds to Multistate Meningitis Outbreak |
| clinical cases | 0.608711 |
| evidence | 0.420812 |
| molecular testing | 0.46092 |
| multistate meningitis outbreak | 0.988118 |
| fungal organisms | 0.468712 |
| CDC scientist Christina | 0.548719 |
| plate | 0.422407 |
| inoculation | 0.418671 |
| navigation Skip | 0.501742 |
| antifungal drug amphotericin | 0.536696 |
| black objects | 0.497611 |
| pus | 0.419993 |
| Special stains | 0.506994 |
| clear area | 0.456343 |
| Scheel | 0.416458 |
| fungus | 0.420915 |
| page options | 0.468121 |
| inflammation | 0.430517 |
| CDC scientist Naureen | 0.546292 |
| CDC scientist | 0.697229 |
| antifungal drug susceptibility | 0.535657 |
|
| results | 0.420009 |
| Bolden | 0.415309 |
| local search Skip | 0.560863 |
| amphotericin drug | 0.475067 |
| susceptibility testing | 0.523339 |
| Exserohilum rostratum | 0.469383 |
| images | 0.416989 |
| list Skip | 0.503366 |
| microscopic examination | 0.647251 |
| patients | 0.438304 |
| blood vessels | 0.510162 |
| CDC scientist Steven | 0.559866 |
| CDC scientist Carol | 0.550302 |
| microscopic slides | 0.489704 |
| Hurst | 0.413213 |
| B. The drug | 0.457474 |
| content Skip | 0.502994 |
| spinal fluid samples | 0.512127 |
| material | 0.411295 |
| blood clots | 0.523667 |
| brain tissue | 0.517178 |
|
CLICK HERE |
| 10220 |
Centers for Disease Control and Prevention |
Html |
en |
Key Facts About Protecting Yourself During a Volcanic Eruption'Volcanoes |
Information on volcanoes and public health. Provided by the Centers for Disease Control and Prevention (CDC). |
| hot gases | 0.759228 |
| volcanic eruptions | 0.761249 |
| dangers | 0.481992 |
| pyroclastic flows | 0.92895 |
| specific actions | 0.695771 |
| best advice | 0.682503 |
| warnings | 0.475816 |
| volcanoes | 0.595728 |
| flashfloods | 0.461705 |
| lava | 0.50078 |
|
| fast-moving flows | 0.908449 |
| ash | 0.487914 |
| debris | 0.599981 |
| attention | 0.46965 |
| local authorities | 0.706592 |
| toxic gases | 0.812348 |
| volcano | 0.481843 |
| hot water | 0.708552 |
| situation | 0.479041 |
|
CLICK HERE |
| 13104 |
Centers for Disease Control and Prevention |
Html |
en |
Work-Related Asthma - 22 States, 2012 |
Jacek M. Mazurek, MD1, Gretchen E. White, MPH1,2 (Author affiliations at end of text). |
| work-exacerbated asthma | 0.439216 |
| data | 0.408307 |
| preventable occupational disease | 0.393577 |
| current asthma prevalence | 0.580771 |
| work-related asthma history | 0.483287 |
| WRA diagnosis | 0.44502 |
| WRA diagnosis§ | 0.477276 |
| adult asthma | 0.486681 |
| current asthma | 0.906004 |
| BRFSS | 0.468103 |
| government agencies | 0.38535 |
| health professionals | 0.38862 |
| Asthma Call-back Survey | 0.506832 |
| landline telephone samples | 0.409592 |
| adult data | 0.384919 |
| Jacek M. Mazurek | 0.392978 |
| BRFSS cellular telephone | 0.413614 |
| cellular telephone–only households | 0.45324 |
| statistical weighting | 0.386793 |
| adult-onset asthma cases | 0.463567 |
| Behavioral Risk Factor | 0.385003 |
| proportion | 0.416089 |
| ever-employed adults | 0.539266 |
| WRA | 0.706362 |
| Ever-employed ACBS participants | 0.44813 |
|
| adverse health outcomes | 0.399589 |
| preventive health practices | 0.392682 |
| states | 0.48361 |
| Occupational Safety | 0.407506 |
| health risk factors | 0.390547 |
| ACBS WRA section | 0.564738 |
| WRA question | 0.464095 |
| weighting methodology | 0.390354 |
| state asthma programs | 0.469449 |
| National Institute | 0.412582 |
| public health | 0.409237 |
| work-related asthma diagnosis | 0.483158 |
| random-digit–dialed telephone survey | 0.388941 |
| BRFSS completion date | 0.392903 |
| BRFSS state coordinators | 0.384654 |
| ACBS median response | 0.431057 |
| CDC-funded ACBS | 0.413222 |
| health | 0.432784 |
| occupational exposures | 0.405398 |
| ACBS question | 0.420994 |
| cellular telephone samples | 0.669985 |
| Occupational Health Branch | 0.387152 |
| WRA cases | 0.450912 |
| asthma symptoms | 0.432503 |
|
CLICK HERE |
| 13586 |
Centers for Disease Control and Prevention |
Html |
en |
Intervals Between PCV13 and PPSV23 Vaccines: Recommendationsof the Advisory Committee on Immunization Practices ACIP |
Please note: An erratum has been published for this article. To view the erratum, please click here. |
| pneumococcal vaccines | 0.644878 |
| added significant complexity | 0.457824 |
| http://www.cdc.gov/vaccines/acip/recs/grade/pneumo-immuno-child.html), immunocompromised adults | 0.511851 |
| immune responses | 0.549255 |
| polysaccharide vaccine | 0.608912 |
| pneumococcal vaccine | 0.744412 |
| recommended dosing intervals | 0.563017 |
| advisory committee | 0.621524 |
| antibody levels | 0.470196 |
| cochlear implants | 0.480156 |
| pneumococcal conjugate vaccine | 0.575524 |
| Vaccines Working Group | 0.53576 |
| pneumococcal vaccine naУÐ?ve | 0.527088 |
| available evidence | 0.467244 |
| PCV13–PPSV23 sequence | 0.791143 |
| improved immune response | 0.464963 |
| Alaska Native adults | 0.498781 |
| intervals | 0.678154 |
| dose | 0.597935 |
| 6-month interval | 0.481323 |
| medical conditions | 0.477893 |
| interval | 0.797181 |
| Cynthia G. Whitney | 0.482518 |
| pneumococcal polysaccharide vaccine | 0.581175 |
| Tamara Pilishvili | 0.486061 |
|
| immunogenicity studies | 0.472477 |
| risk window | 0.466268 |
| vaccines | 0.902831 |
| 1-year interval | 0.662198 |
| United States | 0.585961 |
| age group | 0.540456 |
| 2-month interval | 0.480328 |
| immunocompromising conditions | 0.475282 |
| invasive pneumococcal disease | 0.604941 |
| Immunization Practices | 0.555372 |
| immunocompetent adults | 0.923348 |
| single PPSV23 dose | 0.556485 |
| immune response | 0.561676 |
| ACIP | 0.88574 |
| studies | 0.478753 |
| longer intervals | 0.493998 |
| pneumococcal vaccine series | 0.524383 |
| 8-week interval | 0.470262 |
| conjugate vaccine | 0.602952 |
| serotypes | 0.458122 |
| optimal interval | 0.484117 |
| best available evidence | 0.46327 |
| ACIP recommendations | 0.603598 |
| Vaccine Adverse Events | 0.492002 |
|
CLICK HERE |
| 13948 |
Centers for Disease Control and Prevention |
Html |
en |
Syringe Service Programs for Persons Who Inject Drugs inUrban, Suburban, and Rural Areas - United States, 2013 |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). Often called 'the Voice of CDC,' the MMWR series is the agency's primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. MMWR readership predominately consists of physicians, nurses, public health practitioners, epidemiologists and other scientists, researchers, educators, and laboratorians. |
| risk reduction programs | 0.373475 |
| data | 0.345762 |
| rural ssps | 0.722469 |
| urban SSPs | 0.641815 |
| HIV prevention | 0.376844 |
| risk reduction efforts | 0.443335 |
| rural programs | 0.391322 |
| U.S. SSPs | 0.353057 |
| urban primary locations | 0.36347 |
| prevention services | 0.342676 |
| multiple areas | 0.354059 |
| American Syringe Exchange | 0.445117 |
| rural areas | 0.373763 |
| suburban areas | 0.544242 |
| SSPs | 0.967079 |
| primary suburban locations | 0.442995 |
| effective prevention programs | 0.380477 |
| major urban areas | 0.403978 |
| Viral Hepatitis | 0.352 |
| urban programs | 0.44358 |
| Sinai Beth Israel | 0.444205 |
| rural setting | 0.354967 |
| program directors | 0.434243 |
| syringes | 0.4755 |
| acute HCV infection | 0.400357 |
|
| programs | 0.501328 |
| recent HIV outbreak | 0.375337 |
| HCV infection | 0.79431 |
| United States | 0.689853 |
| PWID | 0.434957 |
| harm reduction services | 0.354005 |
| HCV testing | 0.44342 |
| Substantially fewer SSPs | 0.430563 |
| syringe service programs | 0.389734 |
| Indiana HIV outbreak | 0.355492 |
| drug injection | 0.395773 |
| New York | 0.434234 |
| primary rural locations | 0.384079 |
| HIV incidence | 0.370507 |
| sterile needles | 0.401616 |
| Syringe Exchange Network | 0.447741 |
| services | 0.41194 |
| suburban ssps | 0.615759 |
| HIV | 0.487338 |
| suburban programs | 0.42472 |
| HCV-contaminated syringes | 0.350089 |
| sterile syringes | 0.377322 |
| primary urban locations | 0.374895 |
| previous SSP surveys | 0.342688 |
|
CLICK HERE |
| 15895 |
Centers for Disease Control and Prevention |
Html |
en |
National Action Plan for Child Injury Prevention | Child Safety and Injury Prevention| CDC Injury Center |
null |
| child injury prevention | 0.775097 |
| expert health education | 0.486435 |
| under-recognized public health | 0.494803 |
| unintentional injury prevention | 0.533704 |
| Health Care Management | 0.478255 |
| inform replication strategies | 0.471373 |
| primary care providers | 0.469395 |
| children | 0.471194 |
| Injury Prevention Alliance | 0.516144 |
| home visitation professionals | 0.477069 |
| injury prevention projects | 0.520717 |
| Injury Center | 0.475775 |
| motor vehicle safety | 0.540396 |
| injury risk assessment | 0.503398 |
| home visitation model | 0.476276 |
| community-based prevention programs | 0.482017 |
| home visitation | 0.502651 |
| infant safe sleep | 0.469341 |
| City Health Officials | 0.473417 |
| child injury | 0.969261 |
| death rates | 0.473849 |
| data collection tools | 0.468992 |
| child injury burden | 0.518384 |
| safety centers | 0.495028 |
|
| United States | 0.475832 |
| infant sleep safety | 0.490028 |
| motor vehicle | 0.551999 |
| injury prevention messages | 0.51721 |
| Injury Research Center | 0.501144 |
| county-level Child Death | 0.495583 |
| Prevent Child Injury | 0.527346 |
| brief educational messages | 0.470262 |
| infant suffocation death | 0.474745 |
| injury prevention training | 0.510693 |
| Education Development Center | 0.470959 |
| child unintentional injury | 0.53528 |
| 5-minute safety talks | 0.485424 |
| health care | 0.478686 |
| National Safety Council | 0.490763 |
| Child injury death | 0.541433 |
| child passenger safety | 0.559185 |
| health insurance plans | 0.478168 |
| home safety studies | 0.489586 |
| data collection | 0.46918 |
| home visitation programs | 0.48027 |
| child injury topics | 0.527495 |
| motor vehicle crashes | 0.538671 |
| vehicle safety programs | 0.493481 |
|
CLICK HERE |